Zeinab Asgarian
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Cholesterol and the muscle factory: Bypassing defective LDL clearance in familial hypercholesterolemia.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 15, 2026
Potent enough to restore, controlled enough to endure: Defining therapeutic index of integrating lentiviral liver gene therapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 24, 2026
Impaired nuclear PTEN function drives macrocephaly, lymphadenopathy and late-onset cancer in PTEN hamartoma tumour syndrome.
Journal: Disease models & mechanisms
Published: June 20, 2025
One transgene, two myopathies: an MTM1 'cross gene therapy' for BIN1 deficiency?
Journal: Brain : a journal of neurology
Published: September 06, 2023
Sexual dimorphism in the social behaviour of Cntnap2-null mice correlates with disrupted synaptic connectivity and increased microglial activity in the anterior cingulate cortex.
Journal: Communications biology
Published: September 16, 2022
Genomic investigations of unexplained acute hepatitis in children.
Journal: Nature
Published: July 25, 2022
MTG8 interacts with LHX6 to specify cortical interneuron subtype identity.
Journal: Nature communications
Published: January 19, 2022
Fate mapping reveals mixed embryonic origin and unique developmental codes of mouse forebrain septal neurons.
Journal: Communications biology
Published: September 20, 2021
Hippocampal CA1 Somatostatin Interneurons Originate in the Embryonic MGE/POA.
Journal: Stem cell reports
Published: June 04, 2019
Erratum: Lentiviral vectors can be used for full-length dystrophin gene therapy.
Journal: Scientific reports
Published: August 30, 2017
Lentiviral vectors can be used for full-length dystrophin gene therapy.
Journal: Scientific reports
Published: March 05, 2016
Last Updated: 09/26/2026